tiprankstipranks
Trending News
More News >
Nanjing Leads Biolabs Co., Ltd. Class H (HK:9887)
:9887
Hong Kong Market

Compare Nanjing Leads Biolabs Co., Ltd. Class H (9887) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nanjing Leads Biolabs Co., Ltd. Class H
HK$56.50
HK$11.24B
-34.39
-15.80%
2 Buy
0 Hold
0 Sell
Moderate Buy
Genscript Biotech
HK$14.33
HK$30.65B
52.65%
3 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$39.78
HK$164.43B
35.69
124.24%
3 Buy
0 Hold
0 Sell
Strong Buy
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$58.92B
24.71
72.70%
4 Buy
0 Hold
0 Sell
Strong Buy
Viva Biotech Holdings
HK$1.76
HK$4.36B
23.60
160.76%
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$17.18B
120.12
474.01%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9887
Nanjing Leads Biolabs Co., Ltd. Class H
56.50
-16.80
-22.92%
HK:1548
Genscript Biotech
14.09
4.18
42.18%
HK:2269
Wuxi Biologics (Cayman)
39.78
21.08
112.73%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
22.90
9.22
67.42%
HK:1873
Viva Biotech Holdings
2.06
1.26
157.50%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
43.28
35.78
477.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts